Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424015
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424015
Asia Pacific Immunohistochemistry Market Share, Size, Trends, Industry Analysis Report, By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Research), By End-Use, By Country, And Segment Forecasts, 2024 - 2032
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Asia Pacific immunohistochemistry market size is expected to reach USD 1.1 billion by 2032, according to a new study by Polaris Market Research. The report "Asia Pacific Immunohistochemistry Market Share, Size, Trends, Industry Analysis Report, By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Research), By End-Use, By Country, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The aging process is linked to a heightened susceptibility to infections and autoimmune diseases, primarily due to a compromised immune system. According to the National Council on Aging's 2023 statistics, an estimated 95% of older individuals grapple with at least one chronic disease, encompassing conditions like cancer, heart disease, diabetes, or infectious diseases, with 80% experiencing at least two such conditions. The incidence of cancer sees an 11-fold increase in individuals aged 65 and above compared to those below 65, as reported by the European Society for Medical Oncology. Immunohistochemistry assumes a crucial role in the diagnosis of diseases and the planning of treatment. Consequently, the surge in the geriatric population is anticipated to escalate the demand for immunohistochemistry techniques.
The increasing prevalence of chronic diseases is creating a higher demand for advanced diagnostic techniques. The rise in healthcare spending, both globally and in specific regions, provides the necessary financial support for the adoption of advanced medical technologies. Lastly, continuous technological advancements in disease diagnosis procedures and techniques play a crucial role in enhancing the accuracy and efficiency of immunohistochemistry, contributing to its overall market growth.
Government bodies and prominent organizations consistently engage in initiatives aimed at reducing cancer-related healthcare expenditure by encouraging regular diagnostic examinations. For instance, in February 2023, the Japan International Cooperation Agency (JICA) inked an agreement with the Indian government, extending an Official Development Assistance (ODA) loan exceeding USD 66 million for the development of a super-specialty cancer and research center in Mizoram, India. Additionally, in May 2023, Fujitsu collaborated with Takeda Pharmaceutical & the National Cancer Center Japan in a research project to analyze the recognition, diagnosis, and treatment processes of ovarian cancer patients. Such proactive initiatives by governmental bodies and industry players are anticipated to contribute to the growth of the immunohistochemistry industry in the region.
While these instruments aim to improve efficiency and reproducibility, their upfront expenses present a substantial financial hurdle. The initial acquisition cost encompasses the instrument itself, accompanying software, and necessary accessories, creating a financial barrier, especially for smaller laboratories. For instance, the price of an advanced immunohistochemistry instrument hovers around USD 85,000 to USD 90,000, imposing a substantial burden on hospitals and diagnostic laboratories, particularly in developing economies.
Asia Pacific Immunohistochemistry Market Report Highlights
The antibodies segment held the largest share, primarily due to its rising use in disease diagnosis and several research applications
The hospital segment dominated the market, primarily due to better facilities and a rise in cancer cases
The research institutes segment is expected to grow at the fastest rate due to a rise in research and development activities
The global players include Merck, Danaher, PerkinElmer, Bio SB, Agilent Technologies, Abcam, HiMedia Laboratories, & Sino Biological.
Polaris Market Research has segmented the Asia Pacific immunohistochemistry market report based on product, application, end-use and region:
Asia Pacific Immunohistochemistry, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Other Reagents
- Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Kits
Asia Pacific Immunohistochemistry, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Others
- Research
Asia Pacific Immunohistochemistry, End Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
Asia Pacific Immunohistochemistry, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
Product Code: PM4323
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Asia Pacific Immunohistochemistry Market Insights
- 4.1. Asia Pacific Immunohistochemistry Market - End Use Snapshot
- 4.2. Asia Pacific Immunohistochemistry Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in healthcare spending
- 4.2.1.2. Technological advancement
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Product substitutes
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Asia Pacific Immunohistochemistry Market End Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Asia Pacific Immunohistochemistry Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- 5.3. Antibodies
- 5.3.1. Global Asia Pacific Immunohistochemistry Market, by Antibodies, 2019-2032 (USD Million)
- 5.3.2. Primary Antibodies
- 5.3.2.1. Global Asia Pacific Immunohistochemistry Market, by Primary Antibodies,2019-2032 (USD Million)
- 5.3.3. Secondary Antibodies
- 5.3.3.1. Global Asia Pacific Immunohistochemistry Market, by Secondary Antibodies, 2019-2032 (USD Million)
- 5.4. Reagents
- 5.4.1. Global Asia Pacific Immunohistochemistry Market, by Reagents, 2019-2032 (USD Million)
- 5.4.2. Histological Stains
- 5.4.2.1. Global Asia Pacific Immunohistochemistry Market, by Histological Stains, 2019-2032 (USD Million)
- 5.4.3. Blocking Sera and Reagents
- 5.4.3.1. Global Asia Pacific Immunohistochemistry Market, by Blocking Sera and Reagents, 2019-2032 (USD Million)
- 5.4.4. Chromogenic Substrates
- 5.4.4.1. Global Asia Pacific Immunohistochemistry Market, by Chromogenic Substrates, 2019-2032 (USD Million)
- 5.4.5. Fixation Reagents
- 5.4.5.1. Global Asia Pacific Immunohistochemistry Market, by Fixation Reagents, 2019-2032 (USD Million)
- 5.4.6. Organic Solvents
- 5.4.6.1. Global Asia Pacific Immunohistochemistry Market, by Organic Solvents, 2019-2032 (USD Million)
- 5.4.7. Proteolytic Enzymes
- 5.4.7.1. Global Asia Pacific Immunohistochemistry Market, by Proteolytic Enzymes, 2019-2032 (USD Million)
- 5.4.8. Diluents
- 5.4.8.1. Global Asia Pacific Immunohistochemistry Market, by Diluents, 2019-2032 (USD Million)
- 5.4.9. Other Reagents
- 5.4.9.1. Global Asia Pacific Immunohistochemistry Market, by Other Reagents, 2019-2032 (USD Million)
- 5.5. Equipment
- 5.5.1. Global Asia Pacific Immunohistochemistry Market, by Equipment, 2019-2032 (USD Million)
- 5.5.2. Slide Staining Systems
- 5.5.2.1. Global Asia Pacific Immunohistochemistry Market, by Slide Staining Systems, 2019-2032 (USD Million)
- 5.5.3. Tissue Microarrays
- 5.5.3.1. Global Asia Pacific Immunohistochemistry Market, by Tissue Microarrays, 2019-2032 (USD Million)
- 5.5.4. Tissue Processing Systems
- 5.5.4.1. Global Asia Pacific Immunohistochemistry Market, by Tissue Processing Systems, 2019-2032 (USD Million)
- 5.5.5. Slide Scanners
- 5.5.5.1. Global Asia Pacific Immunohistochemistry Market, by Slide Scanners, 2019-2032 (USD Million)
- 5.5.6. Others
- 5.5.6.1. Global Asia Pacific Immunohistochemistry Market, by Others, 2019-2032 (USD Million)
- 5.6. Kits
- 5.6.1. Global Asia Pacific Immunohistochemistry Market, by Kits, 2019-2032 (USD Million)
6. Asia Pacific Immunohistochemistry Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- 6.3. Diagnostics
- 6.3.1. Global Asia Pacific Immunohistochemistry Market, by Diagnostics, 2019-2032 (USD Million)
- 6.3.2. Cancer
- 6.3.2.1. Global Asia Pacific Immunohistochemistry Market, by Cancer, 2019-2032 (USD Million)
- 6.3.3. Infectious Diseases
- 6.3.3.1. Global Asia Pacific Immunohistochemistry Market, by Infectious Diseases, 2019-2032 (USD Million)
- 6.3.4. Cardiovascular Diseases
- 6.3.4.1. Global Asia Pacific Immunohistochemistry Market, by Cardiovascular Diseases, 2019-2032 (USD Million)
- 6.3.5. Autoimmune Diseases
- 6.3.5.1. Global Asia Pacific Immunohistochemistry Market, by Autoimmune Diseases, 2019-2032 (USD Million)
- 6.3.6. Diabetes Mellitus
- 6.3.6.1. Global Asia Pacific Immunohistochemistry Market, by Diabetes Mellitus, 2019-2032 (USD Million)
- 6.3.7. Nephrological Diseases
- 6.3.7.1. Global Asia Pacific Immunohistochemistry Market, by Nephrological Diseases, 2019-2032 (USD Million)
- 6.3.8. Others
- 6.3.8.1. Global Asia Pacific Immunohistochemistry Market, by Others, 2019-2032 (USD Million)
- 6.4. Research
- 6.4.1. Global Asia Pacific Immunohistochemistry Market, by Research, 2019-2032 (USD Million)
7. Asia Pacific Immunohistochemistry Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- 7.3. Hospitals and Diagnostic Laboratories
- 7.3.1. Global Asia Pacific Immunohistochemistry Market, by Hospitals and Diagnostic Laboratories, 2019-2032 (USD Million)
- 7.4. Research Institutes
- 7.4.1. Global Asia Pacific Immunohistochemistry Market, by Research Institutes, 2019-2032 (USD Million)
- 7.5. Others
- 7.5.1. Global Asia Pacific Immunohistochemistry Market, by Others, 2019-2032 (USD Million)
8. Asia Pacific Immunohistochemistry Market, by Countries
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Asia Pacific Immunohistochemistry Market Assessment, By Countries, 2018-2030 (USD Million)
- 8.2.2. Asia Pacific Immunohistochemistry Market - China
- 8.2.2.1. China: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.2.2. China: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.2.3. China: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.3. Asia Pacific Immunohistochemistry Market - India
- 8.2.3.1. India.: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.3.2. India.: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.3.3. India.: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.4. Asia Pacific Immunohistochemistry Market - Japan
- 8.2.4.1. Japan: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.4.2. Japan: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.4.3. Japan: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.5. Asia Pacific Immunohistochemistry Market - South Korea
- 8.2.5.1. South Korea: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.5.2. South Korea: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.5.3. South Korea: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.6. Asia Pacific Immunohistochemistry Market - Indonesia
- 8.2.6.1. Indonesia: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.6.2. Indonesia: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.6.3. Indonesia: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.7. Asia Pacific Immunohistochemistry Market - Malaysia
- 8.2.7.1. Malaysia: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.7.2. Malaysia: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.7.3. Malaysia: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.8. Asia Pacific Immunohistochemistry Market - Australia
- 8.2.8.1. Australia: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.8.2. Australia: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.8.3. Australia: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
- 8.2.9. Asia Pacific Immunohistochemistry Market - Rest of Asia Pacific
- 8.2.9.1. Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Application, 2018-2030 (USD Million)
- 8.2.9.2. Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Technology, 2018-2030 (USD Million)
- 8.2.9.3. Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by End-Use, 2018-2030 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abcam plc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Agilent Technologies, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Amos Scientific PTY. LTD
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bio SB
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Bio-Rad Laboratories, Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Cell Signaling Technology, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Danaher Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Roche Ltd
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. HiMedia Laboratories
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. IMGENEX INDIA Pvt. Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Immuno-Biological Laboratories Co, Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Kyowa Kirin Co., Ltd.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Merck KGaA
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. PathnSitu Biotechnologies Pvt Ltd
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. PerkinElmer, Inc.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Sino Biological, Inc.
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Thermo Fisher Scientific Inc.
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
Product Code: PM4323
List of Tables
- Table 1 Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 2 Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 3 Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 4 Asia Pacific Immunohistochemistry Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 5 China: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 6 China: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 7 China: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 8 India: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 9 India: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 10 India: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 11 Japan: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 12 Japan: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 13 Japan: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 14 South Korea: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 15 South Korea: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 16 South Korea: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 17 Indonesia: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 18 Indonesia: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 19 Indonesia: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 20 Malaysia: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 21 Malaysia: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 22 Malaysia: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 23 Australia: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 24 Australia: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 25 Australia: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
- Table 26 Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Product, 2019-2032 (USD Million)
- Table 27 Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by Application, 2019-2032 (USD Million)
- Table 28 Rest of Asia Pacific: Asia Pacific Immunohistochemistry Market, by End Use, 2019-2032 (USD Million)
List of Figures
- Figure 1. Asia Pacific Immunohistochemistry Market, 2019-2032 (USD Million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Application
- Figure 7. Asia Pacific Immunohistochemistry Market, by Application, 2022 & 2032 (USD Million)
- Figure 8. Market by Product
- Figure 9. Asia Pacific Immunohistochemistry Market, by Product, 2022 & 2032 (USD Million)
- Figure 10. Market by End Use
- Figure 11. Asia Pacific Immunohistochemistry Market, by End Use, 2022 & 2032 (USD Million)
- Figure 12. Asia Pacific Immunohistochemistry Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 13. Strategic Analysis - Asia Pacific Immunohistochemistry Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.